Potential Tweaks To IRA Not Enough To Quell Innovation Harms, Industry Says

Lawmakers on both sides of the aisle have been considering updating the Inflation Reduction Act to ensure the law’s provisions offer cost savings for seniors on prescription drugs without disincentivizing the development of certain types of drugs; but the drug industry maintains that stepping away from government price controls completely is the best way to avoid a bleak future for innovation, even if pending legislation would address some of the law’s issues. “With important proposals such as these already being...